Prof  Mallikarjuna BP

Prof Mallikarjuna BP


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2009 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
PBProf Mallikarjuna BP
Prof Mallikarjuna BP
BSB.S. Sastry
B.S. Sastry
GKG.V. Suresh Kumar
G.V. Suresh Kumar
YRY. Rajendraprasad
Y. Rajendraprasad
SCS.M. Chandrashekar
S.M. Chandrashekar
KSK. Sathisha
K. Sathisha

26 April 2024 in Computational Biology and Chemistry
Verified
Journal Article
Closed access
YMYasmin H. Momin
Yasmin H. Momin
VYV.C. Yeligar
V.C. Yeligar
MSM.G. Saralaya
M.G. Saralaya
GDG. Dharmamoorthy
G. Dharmamoorthy
PBProf Mallikarjuna BP
Prof Mallikarjuna BP
SASyed Mohammed Basheeruddin Asdaq
Syed Mohammed Basheeruddin Asdaq

1 July 2024 in Saudi Pharmaceutical Journal
Verified
Journal Article
Open access
SPSwapnil S. Patil
Swapnil S. Patil
PKPreeti Khulbe
Preeti Khulbe
MNManojkumar M. Nitalikar
Manojkumar M. Nitalikar
KDKuntal Das
Kuntal Das
PBProf Mallikarjuna BP
Prof Mallikarjuna BP
SASyed Mohammed Basheeruddin Asdaq
Syed Mohammed Basheeruddin Asdaq
Objective: Skin cancer refers to the pathological condition characterized by the proliferation of atypical skin cells in an uncontrolled manner. Plant-based products such as bixin although show promising anticancer properties, but maintaining their stability in a formulation is a difficult task. The objective of the research is to formulate a silver nanoparticle gel preparation of bixin and evaluate its anticancer properties. Methods: The extract from Bixa orellana seed was prepared by hot extraction technique to isolate the active ingredient, bixin. A green synthesis approach was utilized for preparing the silver nanoparticle gel of bixin (BOAgNPs). Characterization of silver nanoparticles was done using FTIR, scanning electron microscopy, compatibility study, homogeneity testing, pH evaluation, and drug content determination. The in-vitro anticancer activity was performed using cell lines (B16F10) and in-vivo by chemical carcinogen (7,12-dimethylbenz (a) anthracene) in mice. Results: The BOAgNPs-loaded topical gel was found to be homogeneous (clear orange color) and pH-compatible (pH ≈ 6.66) with the skin. The characterization studies indicated the presence of all functional groups in the formulation. An optimized batch of bixin-nano gel showed about 60% inhibitory effects on B16F10 cell lines (in-vitro activity) when equated with a reference drug, 5-fluorouracil. The in-vivo anticancer study suggested suppression of tumorigenesis and promotion of the healing process with bixin-nano gel application on the skin. Conclusion: The results suggested the promising anticancer property of bixin when formulated in silver nanoparticle gel. The preparation of silver particles nano gel with bixin might provide an effective alternative option for treating skin cancers, provided more research complements the findings of the present study.

6 December 2021 in Asian Journal of Chemistry
Verified
Journal Article
Open access
AGArti Gupta
Arti Gupta
SKSandeep Kumar
Sandeep Kumar
VSVijay Kumar Singh
Vijay Kumar Singh
PBProf Mallikarjuna BP
Prof Mallikarjuna BP
NDNeerupma Dhiman
Neerupma Dhiman
ASArchana Sharma
Archana Sharma
The combination of different heterocyclic rings to form a multifunctional compound is a new approach to get the potent and selective compounds, which can act as antiepileptic drugs. In this study we designed and synthesized the hybrid of the coumarin ring with sulfonamide moiety. Coumarin sulfonamide hybrids (CS1-CS7) were synthesized by Knoevenagel condensation of methyl anilinosulfonyl acetate with substituted salicyaldehyde in the presence of catalytic base. The synthesized hybrid compounds were characterized by means of mass, 1H & 13C NMR and FTIR spectroscopy, moreover antiepileptic activity was screened through seizure model of epilepsy using pentylenetetrazole and maximal electroshock. According to results, compound CS-2 remained to be highest potent and presented significant protection at 60 mg/kg in both the seizure models. Furthermore, compound CS-2 was also evaluated for biochemical and a histopathological study in which no significant results were obtained. In addition to former activities, compound CS-2 was also examined for liver toxicity.